Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.570
-0.050 (-1.91%)
May 29, 2026, 4:00 PM EDT - Market closed
Organogenesis Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 514.7 | 564.17 | 482.04 | 433.14 | 450.89 | 467.36 | |
Revenue Growth (YoY) | 12.20% | 17.04% | 11.29% | -3.94% | -3.52% | 38.15% |
Cost of Revenue | 139.57 | 137.52 | 115.74 | 106.48 | 105.02 | 114.2 |
Gross Profit | 375.13 | 426.65 | 366.3 | 326.66 | 345.87 | 353.16 |
Selling, General & Admin | 318.91 | 326.24 | 294.51 | 269.75 | 283.81 | 250.2 |
Research & Development | 49.06 | 44.54 | 50.27 | 44.38 | 39.76 | 30.74 |
Other Operating Expenses | 4.61 | 11.18 | 22.8 | - | - | - |
Total Operating Expenses | 372.58 | 381.95 | 367.59 | 314.13 | 323.57 | 280.94 |
Operating Income | 2.55 | 44.69 | -1.28 | 12.53 | 22.3 | 72.22 |
Interest Expense | 1.7 | 2.28 | -1.54 | -2.19 | -2.01 | -7.24 |
Other Non-Operating Income (Expense) | 0.03 | -0.01 | 0.02 | 0.06 | -0.01 | -1.9 |
Total Non-Operating Income (Expense) | 1.73 | 2.28 | -1.52 | -2.13 | -2.02 | -9.13 |
Pretax Income | 4.28 | 46.97 | -2.81 | 10.39 | 20.28 | 63.09 |
Provision for Income Taxes | 1.56 | 9.94 | -3.67 | 5.45 | 4.75 | -31.12 |
Net Income | -18.71 | 20.02 | -0.94 | 4.95 | 15.53 | 94.2 |
Net Income Attributable to Preferred Dividends | -21.43 | -17.01 | -1.8 | - | - | - |
Net Income to Common | -18.71 | 20.02 | -0.94 | 4.95 | 15.53 | 94.2 |
Net Income Growth | - | - | - | -68.16% | -83.51% | 446.61% |
Shares Outstanding (Basic) | 127 | 127 | 132 | 131 | 130 | 128 |
Shares Outstanding (Diluted) | 129 | 130 | 132 | 133 | 132 | 134 |
Shares Change (YoY) | -1.38% | -1.08% | -0.81% | 0.27% | -0.96% | 20.03% |
EPS (Basic) | -0.18 | 0.16 | -0.01 | 0.04 | 0.12 | 0.73 |
EPS (Diluted) | -0.19 | 0.15 | -0.01 | 0.04 | 0.12 | 0.70 |
EPS Growth | - | - | - | -66.67% | -82.86% | 366.67% |
Shares Outstanding | 128.68 | 126.95 | 125.73 | 131.32 | 130.92 | 128.68 |
Free Cash Flow | 37.77 | -3.77 | -0.87 | -21.23 | -9.04 | 30.76 |
Free Cash Flow Per Share | 0.29 | -0.03 | -0.01 | -0.16 | -0.07 | 0.23 |
Gross Margin | 72.88% | 75.62% | 75.99% | 75.42% | 76.71% | 75.56% |
Operating Margin | 0.50% | 7.92% | -0.27% | 2.89% | 4.95% | 15.45% |
Profit Margin | -1.84% | 6.56% | 0.18% | 1.14% | 3.44% | 20.16% |
FCF Margin | 7.34% | -0.67% | -0.18% | -4.90% | -2.00% | 6.58% |
EBITDA | 35.57 | 71.63 | 24.09 | 35.97 | 40.34 | 88.89 |
EBITDA Margin | 6.91% | 12.70% | 5.00% | 8.31% | 8.95% | 19.02% |
EBIT | 2.55 | 44.69 | -1.28 | 12.53 | 22.3 | 72.22 |
EBIT Margin | 0.50% | 7.92% | -0.27% | 2.89% | 4.95% | 15.45% |
Effective Tax Rate | 36.47% | 21.16% | 130.67% | 52.42% | 23.42% | -49.32% |